PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

amphotericin B

Verify with FDA → · CMS NADAC pricing →

Brand names: Ambisome, Fungizone

Polyene Antifungal Rx

Amphotericin B liposome is an antifungal medicine. It fights serious fungal infections in your body.

Drug Shortage Alert

amphotericin B is currently listed as to be discontinued by the FDA. Affected manufacturer: Leadiant Biosciences, Inc..

View all drug shortages →

What it does

This medicine treats fungal infections like aspergillosis, candidiasis, and cryptococcosis.

Common side effects

Abdominal pain, Weakness, Back pain

Key warnings

This medicine is not interchangeable with other amphotericin B products.

How It Works

Amphotericin B liposome belongs to a class of drugs called polyene antifungals. It works by binding to the membrane of the fungal cells. This binding disrupts the fungal cell membrane, causing the cell to die.

How to Take It

This medicine is given through an IV into your vein over about 2 hours. Your doctor will decide the right dose for you based on your infection. The usual dose is 3 to 6 mg/kg per day, depending on the infection being treated. The IV line should be flushed with a special solution before use.

Pregnancy & Breastfeeding

Tell your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby. Talk to your doctor about the risks and benefits of using this medicine during pregnancy or while breastfeeding.

Missed Dose

Call your doctor right away if you miss an appointment to receive your dose. They will tell you when to reschedule.

Storage

Store the medicine in its original packaging until you are ready to use it.

Side Effects (from patient reports)

Based on 11,200 FDA adverse event reports.

The medicine is not working
3,939
Using the medicine for a condition it's not approved for
1,911
Fever
974
Condition got worse
842
Fever with low white blood cell count
650
Sudden kidney damage
625
Blood infection
612
Lung infection
578
Low potassium
541
Failure of multiple organs
528

FDA Adverse Event Report Analysis

Detailed analysis of 17,512 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 1999–2025.

Total Reports

17,512

Death-Related Reports

6,407

Hospitalization Reports

7,521

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 6,479 (40%)
Male 9,447 (59%)

Age Distribution

0–17 2,871
18–44 3,561
45–64 4,641
65–74 2,212
75+ 994

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
1 DRUG INEFFECTIVE 3,940
2 OFF LABEL USE 1,911
3 PYREXIA 972
4 CONDITION AGGRAVATED 841
5 FEBRILE NEUTROPENIA 650
6 ACUTE KIDNEY INJURY 625
7 SEPSIS 613
8 PNEUMONIA 576
9 HYPOKALAEMIA 542
10 MULTIPLE ORGAN DYSFUNCTION SYNDROME 528
11 RENAL IMPAIRMENT 528
12 PRODUCT USE IN UNAPPROVED INDICATION 521
13 DEATH 516
14 NEUTROPENIA 504
15 RESPIRATORY FAILURE 491

Reactions in Death Reports

DRUG INEFFECTIVE 2,376
OFF LABEL USE 634
DEATH 516
MULTIPLE ORGAN DYSFUNCTION SYNDROME 487
SEPSIS 403
CONDITION AGGRAVATED 373
RESPIRATORY FAILURE 370
SEPTIC SHOCK 336
PNEUMONIA 323
PYREXIA 315

Reactions in Hospitalization Reports

DRUG INEFFECTIVE 1,462
OFF LABEL USE 694
PYREXIA 633
FEBRILE NEUTROPENIA 430
CONDITION AGGRAVATED 415
ACUTE KIDNEY INJURY 406
PNEUMONIA 389
SEPSIS 355
RESPIRATORY FAILURE 314
MULTIPLE ORGAN DYSFUNCTION SYNDROME 303

Source: FDA FAERS (Adverse Event Reporting System) FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

This medicine is not interchangeable with other amphotericin B products. Different versions of amphotericin B act differently in the body. Make sure you always get the correct medicine.

Known Drug Interactions

Nephrotoxic agents Concomitant administration of cidofovir injection and agents with nephrotoxic potential [e.g., intravenous aminoglycosides (e.g., tobramycin, gentamicin, and amikacin), amphotericin B, foscarnet, intravenous pentamidine, vancomycin, and nonsteroidal anti-inflammatory agents] is contraindicated.

Mechanism: Both drugs can cause damage to the kidneys. Combining them makes kidney injury much more likely.

What to do: This drug combination should be avoided. Your doctor will need to use a different medicine that is safer for your kidneys.

moderate ganciclovir

Cyclosporine or amphotericin B Unknown Monitor renal function when Ganciclovir Injection is coadministered with cyclosporine or amphotericin B because of potential increase in serum creatinine [see Warnings and Precautions (5.2)]. (7) Cyclosporine or amphotericin B: When coadministered with ganciclovir, the risk of nephrotoxicity may be increased.

Mechanism: Both of these medications can be toxic to the kidneys when used at the same time. This combination may lead to a rise in serum creatinine levels, indicating kidney stress.

What to do: Your doctor will need to check your kidney function frequently while you are on both drugs. Ensure you stay hydrated and follow all scheduled lab work.

Cyclosporine or amphotericin B Unknown Monitor renal function when valganciclovir is coadministered with cyclosporine or amphotericin B because of potential increase in serum creatinine [see Warnings and Precautions (5.2)]. ( 7 ) Cyclosporine or amphotericin B: When coadministered with valganciclovir, the risk of nephrotoxicity may be increased.

Mechanism: Both of these drugs can be hard on the kidneys, and using them at the same time increases the chance of kidney injury.

What to do: Your doctor should check your kidney function frequently to ensure the organs are working properly during treatment.

Azoles (e.g., ketoconazole, miconazole, clotrimazole, fluconazole, etc.) In vitro and in vivo animal studies of the combination of amphotericin B and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin B.

Mechanism: Using these two antifungal medicines together might make the fungus harder to kill and resistant to the treatment.

What to do: Your doctor will monitor your progress closely to ensure the infection is being treated effectively.

7.5 Amphotericin B Liposome for Injection Administration of multiple doses of anidulafungin and liposomal amphotericin B to patients resulted in no significant alteration in the steady state pharmacokinetics of anidulafungin. No dosage adjustment of anidulafungin is needed when it is co-administered with liposomal amphotericin B [see Clinical Pharmacology (12.3) ] .

Mechanism: These medications do not interfere with each other's levels in the body. They do not change how the body processes the medicine.

What to do: No dose adjustment is required when taking these two medications together.

Check all your medications →

Common Questions

Can I switch to a different brand of amphotericin B?
No, this medicine is not interchangeable with other amphotericin B products.
How long will I need to take this medicine?
Your doctor will decide how long you need to take this medicine based on your infection.
What should I do if I feel sick during the infusion?
Tell your doctor or nurse right away if you feel sick during the infusion. They may need to slow down the infusion rate.
Can I take other medicines with this one?
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Will this medicine affect my kidneys?
This medicine can sometimes affect your kidneys. Your doctor will monitor your kidney function while you are taking this medicine.
Can this medicine cause an allergic reaction?
This medicine can cause an allergic reaction. Get medical help right away if you have any signs of an allergic reaction, such as rash, itching, swelling, or trouble breathing.
How will I know if the medicine is working?
Your doctor will monitor your condition to see if the medicine is working.
What if I have a reaction to the blood transfusion?
Tell your doctor or nurse right away if you have any signs of a reaction to the blood transfusion, such as chills, fever, or rash.
Can this medicine cause low potassium?
Yes, this medicine can cause low potassium. Your doctor will monitor your potassium levels while you are taking this medicine.
How is this medicine given?
This medicine is given through an IV into your vein.
What are the common side effects of amphotericin B?
The most commonly reported side effects of amphotericin B include Abdominal pain, Weakness, Back pain, Chills, Pain. Based on 11,200 FDA adverse event reports. Always consult your healthcare provider about potential side effects.
Does amphotericin B interact with other medications?
Yes, amphotericin B has 12 known drug interactions. Notable interactions include cidofovir, ganciclovir, valganciclovir. Always inform your doctor about all medications you are taking.
What drug class is amphotericin B?
amphotericin B belongs to the Polyene Antifungal drug class. It requires a prescription (Rx). This medicine treats fungal infections like aspergillosis, candidiasis, and cryptococcosis.
Is amphotericin B safe during pregnancy?
Tell your doctor if you are pregnant or plan to become pregnant. It is not known if this medicine will harm your unborn baby. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.
Has amphotericin B been recalled?
There are 2 recalls associated with amphotericin B products. Out of specification for assay. Check the recalls section below for full details and affected products.
Is amphotericin B currently in shortage?
Yes, amphotericin B is currently listed as to be discontinued by the FDA. Affected manufacturer: Leadiant Biosciences, Inc.. Visit the FDA Drug Shortages database for the latest updates.

Active Recalls

Class II April 19, 2024

Out of specification for assay

SUN PHARMACEUTICAL INDUSTRIES INC

Class II May 15, 2014

Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.

Franck's Lab Inc dba Trinity Care Solutions

Related Medications in Polyene Antifungal

Other drugs grouped near amphotericin B — same-class peers and common alternatives.

Compare amphotericin B vs acyclovir side-by-side →

Medication Guides

Related Health & Safety Data

Save on amphotericin B

Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.

Disclosure: This link may earn us a commission at no extra cost to you. See our terms.

What the FDA Data Shows for amphotericin B

The FDA label for amphotericin B (sold under brand names such as Ambisome, Fungizone) classifies it as a prescription-only medication in the Polyene Antifungal class. This medicine treats fungal infections like aspergillosis, candidiasis, and cryptococcosis. Official labeling lists 24 commonly reported side effects, including Abdominal pain, Weakness, Back pain.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 11,200 voluntary reports. The database also lists 12 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated major severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation — a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 2 recall records on file), and patent information further shape supply and switching decisions. This page summarizes public FDA data for educational purposes only and is not a substitute for professional medical advice — always consult a licensed healthcare provider before starting, stopping, or changing any medication.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Shortage status: FDA Drug Shortages Database.

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. Always consult a healthcare professional before making medication decisions.

Last updated: January 21, 2025

All federal data sources used on this page